Used in pharmaceutical research as a selective sigma receptor ligand, particularly showing affinity for the sigma-1 receptor subtype. This compound is investigated for its potential role in neurological and psychiatric disorders due to the involvement of sigma receptors in pain modulation, neuroprotection, and cognitive functions. It may serve as a lead compound in developing treatments for conditions such as neuropathic pain, depression, and substance use disorders. Its structure allows for blood-brain barrier penetration, making it suitable for central nervous system-targeted therapies. Often employed in receptor binding assays and in vivo studies to elucidate sigma receptor pharmacology.